Taiwan · Delayed Price · Currency is TWD BioLASCO Taiwan Statistics
Total Valuation
BioLASCO Taiwan has a market cap or net worth of TWD 732.50 million. The enterprise value is 694.41 million.
| Market Cap | 732.50M |
| Enterprise Value | 694.41M |
Important Dates
The last earnings date was Friday, March 27, 2026.
| Earnings Date | Mar 27, 2026 |
| Ex-Dividend Date | Aug 7, 2025 |
Share Statistics
BioLASCO Taiwan has 25.61 million shares outstanding.
| Current Share Class | 25.61M |
| Shares Outstanding | 25.61M |
| Shares Change (YoY) | n/a |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 29.71% |
| Owned by Institutions (%) | n/a |
| Float | 16.18M |
Valuation Ratios
The trailing PE ratio is 16.88.
| PE Ratio | 16.88 |
| Forward PE | n/a |
| PS Ratio | 2.78 |
| PB Ratio | 1.74 |
| P/TBV Ratio | 1.74 |
| P/FCF Ratio | 23.07 |
| P/OCF Ratio | 13.49 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.32, with an EV/FCF ratio of 21.87.
| EV / Earnings | 16.00 |
| EV / Sales | 2.63 |
| EV / EBITDA | 11.32 |
| EV / EBIT | 13.97 |
| EV / FCF | 21.87 |
Financial Position
The company has a current ratio of 2.33, with a Debt / Equity ratio of 0.22.
| Current Ratio | 2.33 |
| Quick Ratio | 1.94 |
| Debt / Equity | 0.22 |
| Debt / EBITDA | 1.49 |
| Debt / FCF | 2.86 |
| Interest Coverage | 24.32 |
Financial Efficiency
Return on equity (ROE) is 10.33% and return on invested capital (ROIC) is 10.75%.
| Return on Equity (ROE) | 10.33% |
| Return on Assets (ROA) | 5.20% |
| Return on Invested Capital (ROIC) | 10.75% |
| Return on Capital Employed (ROCE) | 9.93% |
| Weighted Average Cost of Capital (WACC) | 5.10% |
| Revenue Per Employee | 2.90M |
| Profits Per Employee | 476,824 |
| Employee Count | 91 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 5.76 |
Taxes
In the past 12 months, BioLASCO Taiwan has paid 7.47 million in taxes.
| Income Tax | 7.47M |
| Effective Tax Rate | 14.69% |
Stock Price Statistics
The stock price has decreased by -15.63% in the last 52 weeks. The beta is 0.23, so BioLASCO Taiwan's price volatility has been lower than the market average.
| Beta (5Y) | 0.23 |
| 52-Week Price Change | -15.63% |
| 50-Day Moving Average | 29.46 |
| 200-Day Moving Average | 31.15 |
| Relative Strength Index (RSI) | 43.08 |
| Average Volume (20 Days) | 10,646 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, BioLASCO Taiwan had revenue of TWD 263.81 million and earned 43.39 million in profits.
| Revenue | 263.81M |
| Gross Profit | 106.05M |
| Operating Income | 49.46M |
| Pretax Income | 50.86M |
| Net Income | 43.39M |
| EBITDA | 61.53M |
| EBIT | 49.46M |
| Earnings Per Share (EPS) | n/a |
Balance Sheet
The company has 128.85 million in cash and 90.76 million in debt, with a net cash position of 38.09 million or 1.49 per share.
| Cash & Cash Equivalents | 128.85M |
| Total Debt | 90.76M |
| Net Cash | 38.09M |
| Net Cash Per Share | 1.49 |
| Equity (Book Value) | 420.05M |
| Book Value Per Share | n/a |
| Working Capital | 118.04M |
Cash Flow
In the last 12 months, operating cash flow was 54.32 million and capital expenditures -22.57 million, giving a free cash flow of 31.75 million.
| Operating Cash Flow | 54.32M |
| Capital Expenditures | -22.57M |
| Depreciation & Amortization | 12.07M |
| Net Borrowing | -17.41M |
| Free Cash Flow | 31.75M |
| FCF Per Share | 1.24 |
Margins
Gross margin is 40.20%, with operating and profit margins of 18.75% and 16.45%.
| Gross Margin | 40.20% |
| Operating Margin | 18.75% |
| Pretax Margin | 19.28% |
| Profit Margin | 16.45% |
| EBITDA Margin | 23.32% |
| EBIT Margin | 18.75% |
| FCF Margin | 12.03% |
Dividends & Yields
This stock pays an annual dividend of 1.50, which amounts to a dividend yield of 5.24%.
| Dividend Per Share | 1.50 |
| Dividend Yield | 5.24% |
| Dividend Growth (YoY) | -9.09% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 88.54% |
| Buyback Yield | n/a |
| Shareholder Yield | 5.24% |
| Earnings Yield | 5.92% |
| FCF Yield | 4.33% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on July 30, 2018. It was a forward split with a ratio of 1.055.
| Last Split Date | Jul 30, 2018 |
| Split Type | Forward |
| Split Ratio | 1.055 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |